Malignant mixed mullerian tumor in two patients receiving tamoxifen therapy
Languages of publication
Patients with breast cancer exhibit an increased risk in developing neoplasms of other organs. In the case of the endometrium, the increased risk might be due to tamoxifen adjuvant therapy. We present two cases of homologous malignant mixed mullerian tumor (MMMT) of the uterine in two women, 77-year-old and 76-year-old, respectively, after tamoxifen treatment for postmenopausal breast cancer with positive estrogen receptors. The findings for two patients were studied and compared with similar ones discussed in the relevant literature.
Publication order reference